Merck's new injectable cancer drug, Keytruda Qlex, promises to transform patient treatment with a quick administration time and flexible dosing, all while maintaining effectiveness. Available in late September, this shift is critical as the market braces for biosimilar competition.
A groundbreaking study shows that taking a low dose of aspirin daily can significantly reduce the risk of colorectal cancer recurrence by 55% for patients with specific PI3K pathway mutations. Learn how this common pill could change lives!
Elissa Kalver, diagnosed with HER2-positive metastatic breast cancer at 34, shares her inspiring journey through aggressive treatments, clinical trials, and living life to the fullest despite her diagnosis.
A recent study reveals that high sucralose intake may hinder immunotherapy effectiveness in cancer patients. Discover how arginine supplements could be the key to improving outcomes.
At just 11 months old, Jonny Terrell was diagnosed with a rare and aggressive cancer. Now in remission, his family's journey highlights the struggles and triumphs of battling childhood cancer.
The World Health Organization has released its updated Essential Medicines Lists, adding crucial cancer and diabetes treatments, aiming to improve global health access.
Former President Joe Biden recently had Mohs surgery to treat skin cancer, raising concerns over his health. This procedure, known for its precision, aims to remove cancerous tissue while preserving healthy skin. Learn more about Biden's health updates and treatment.
A groundbreaking study reveals that a new mRNA vaccine can activate the immune system and significantly shrink tumors in mice, sparking hope for a universal cancer vaccine that could revolutionize treatment methods.
A groundbreaking study from the University of Florida reveals that a new mRNA vaccine could trigger a powerful immune response against various cancers, offering hope for treatment-resistant tumors. Researchers found that this approach might lead to a universal cancer vaccine that could complement existing therapies.
The US government has made a controversial move by terminating $500 million in grants for mRNA vaccine research, a technology that saved millions during COVID-19. Experts warn this could hinder future health advancements.
